With the strategic alliance "M1 – Munich Medicine Alliance," the partners want to strategically develop the exceptional strengths of Munich medicine to a world-class level. To this end, joint infrastructures for conducting clinical studies, platform technologies, and data integration are to be created. Translation projects are intended to accelerate the transfer of new knowledge and technologies from the laboratory to the patient.
On July 2, a ceremony including podium discussions took place at the Allerheiligen-Hofkirche of the Residenz München. Bavaria's Minister of Science, Markus Blume, opened the ceremony and stated how “Munich is becoming the medical capital of the republic” and that to keep pace with the best of the world “we must and will catch up in the field of clinical trials to make Germany the pharmacy of the world again. We must and will break new ground in using health data; together with the possibilities of artificial intelligence, groundbreaking advances for new forms of therapy can be expected here. And we want to and will ensure that scientific knowledge reaches the bedside directly and perhaps also enables new business models.“ Our member Matthias Tschöp, scientific director of Helmholtz Munich and president-elect of LMU comments: “With the M1 Alliance, Munich is taking the lead in Germany. The merger of the most important players in medicine, from health research to university hospitals, will unlock enormous synergies and thus potential for medical research. All participants, partners, industry, and patients will benefit from this."
The ceremony included two panel discussions. One was on “the future of medicine and the most important drivers of medical progress”, in which our member Lena Burbulla participated.
